Evans Daron

CFO Evans Daron bought 10,000 shares at $2.85 on 2026-03-30; prior same-ticker buys 80% well-timed at 90d, current price -72.1% from 52-week high.

CFO Evans Daron purchased 10,000 shares at $2.85, bringing holdings to 414,462 shares—a 2.5% increase. His track record at RZLT demonstrates strong timing discipline: 4 of 5 prior trades were well-timed on the 90-day basis, with three consecutive December purchases returning 52.0% to 54.0% in 30 days and 45.0% to 46.9% in 90 days. However, the company remains unprofitable with full-year net income of -$22,774,000.00, and the stock is currently -72.1% from its 52-week high of $10.94. The insider's cross-ticker buy history shows an 83.33% 90-day win rate with +59.6% average 90-day return, suggesting execution capability that has translated to RZLT specifically in recent months. The timing of this purchase—after a -5.0% 30-day decline—occurs in context of structural unprofitability and deep valuation drawdown from peak.

CFO Evans Daron bought 45,000 shares at $1.77 avg; stock down 85.1% from 52-week high, held post-transaction shows net short position now closed

Evans Daron, CFO of Rezolute, executed 3 separate purchases totaling 45,000 shares for $79,577.50 at an average price of $1.77 on 2025-12-15, converting a pre-transaction short position of -38,000 shares into a long position of 7,000 shares. The timing occurs at a significant trough: the stock trades 85.1% below its 52-week high of $10.94, having declined 83.5% over the past 30 days. His prior trades at Rezolute show a 3-of-4 pattern of well-timed entry points at the 90-day mark, with two prior buys returning +44.9% and +101.0% respectively; however, fundamentals remain pressured with the company reporting $-18,150,000.00 net income over its most recent full fiscal year. A cluster of buy activity has emerged, with 2 other insiders also purchasing within the past 14 days, suggesting coordinated conviction or pre-planned acquisition activity. The extreme price decline and insider accumulation at these depressed levels warrants scrutiny of whether this represents informed repositioning or response to undisclosed material developments.

CFO Evans Daron bought 5,000 shares of RZLT at $4.05; cluster pattern with 2 other insiders buying within 14 days amid 90-day +55.3% recovery.

Evans Daron purchased 5,000 shares at $4.05, bringing his total holding to 268.9K shares. This purchase occurs within a cluster of 3 insider buys across a 14-day window, a notable signal of coordinated confidence from the executive team. The timing context is significant: the stock has recovered +55.3% over 90 days and is currently +9.0% over 30 days, yet remains -28.9% from its 52-week high of $5.96. Daron's prior trades at RZLT show a 60% win rate at the 90-day mark (3 of 5 prior buys yielded positive 90d returns), though the company remains unprofitable with net income of $-18.9M against a market cap of $362.6M. The convergence of cluster buying activity, recovery momentum, and a CFO's willingness to add shares despite ongoing losses warrants tracking for whether this reflects insider assessment of near-term operational improvement or structural valuation opportunity.

CFO Evans Daron purchases 20,000 shares (20.0K) for $57,700 at RZLT; post-trade holdings 23,000 shares (+666.7%); stock down 50.8% from 52-week high.

Evans Daron, CFO of Rezolute Inc., executed 2 separate purchases totaling 20,000 (20.0K shares) for $57,700.00 on 2025-03-26, raising his holdings from 3,000 to 23,000 shares—a 666.7% increase. The company is unprofitable with net income of $-15,730,000.00 and a market cap of $177,368,795.25. The stock has declined 50.8% from its 52-week high of $5.96 and is down 34.3% over the prior 30 days and 40.9% over 90 days. Across his 5 prior open-market purchases at this ticker, Daron achieved positive 90-day returns on 3 occasions, though his two most recent RZLT buys (2024-12-18 and 2024-12-12) resulted in 90-day losses of -21.4% and -18.3% respectively, differing materially from his cross-ticker track record average of +70.6% over 90 days. This large-scale accumulation during steep declines warrants close monitoring of whether the stock stabilizes or continues deteriorating.

CFO Evans Daron bought 10,000 RZLT shares at $4.29 on 2024-12-18; stock now $4.08 (-31.5% from 52-week high); 4 of 4 prior buys at RZLT well-timed at 90-day mark.

Evans Daron's purchase of 10,000 shares at $4.29 represents a 7.1% increase to his holdings at Rezolute, a company with negative net income of $-15,378,000.00 over the most recent fiscal year. His cross-ticker track record shows 10 prior open-market buys with an average 90-day return of +90.7% and 100% win rate, though at RZLT specifically his 4 prior measurable buys all posted positive 90-day returns (+16.4%, +22.9%, +22.3%, +38.6%), indicating consistent timing skill at this ticker. The current stock price of $4.08 is -31.5% from the 52-week high and -16.2% over 30 days, establishing a depressed context for the purchase, though the company remains unprofitable. His persistent accumulation pattern at RZLT—6 buys since May 2024—contrasts sharply with the company's negative fundamentals and recent price weakness, warranting analysis of what visibility into operations or strategy may inform his continued conviction.

CFO Daron Evans bought 9,000 RZLT shares at $4.60; 5 of 5 prior RZLT buys posted +29.2% to +205.0% 90d gains.

CFO Daron Evans purchased 9,000 shares at $4.60, expanding his holdings to 140,900 shares (+6.8% increase). This marks his sixth open-market purchase of Rezolute stock in 2024, following a remarkable pattern: all 5 prior RZLT buys achieved positive 90-day returns, ranging from +29.2% to +205.0%, with 100% of those trades well-timed at the 90-day mark. The current context is challenging—the stock trades at $4.64, down 22.2% from its 52-week high and 20.3% over the past 30 days—yet the CFO deployed capital despite the company's unprofitable status (net loss of $15.4M in the most recent full fiscal year). His cross-ticker track record across 9 prior open-market buys shows an average 90-day return of +90.7% with a 100.0% win rate, suggesting consistent skill in identifying buying opportunities. The repeated accumulation at weakness, combined with his historical execution record, stands out against the current negative momentum and fundamental headwinds.

CFO Evans Daron acquired 10,549 shares of RZLT at $5.04; 5 of 5 prior buys at this ticker well-timed; unprofitable fundamentals.

CFO Evans Daron purchased 10,549 shares at $5.04, increasing his holdings by 8.7% to 131,900 shares. His prior pattern at RZLT is noteworthy: across 5 separate buys dating back to March 2025, all 5 were well-timed at the 90-day mark, with returns ranging from +29.2% to +205.0%. The current price of $4.95 sits 17.0% below the 52-week high and down 11.3% over 30 days, creating a lower entry point than recent price history. However, Rezolute's most recent full fiscal year showed net income of $-15,378,000.00 and the company remains unprofitable. The convergence of strong insider buy-timing history at this ticker against deteriorating fundamentals and recent downward price momentum warrants scrutiny of the business trajectory underlying this acquisition.

CFO Evans Daron purchased 40,000 shares of RZLT at $4.04 (total $161.6K) on 2024-06-14, adding to 5 prior buys this year; stock now at $3.95.

Evans Daron, CFO of Rezolute, purchased 40,000 shares at $4.04 on 2024-06-14 for $161,568.00, establishing his first RZLT position. This buy is the sixth insider acquisition of RZLT since March 2024 and follows a strong 30-day performance of +49.1% and 90-day performance of +121.9% from the March transaction date. His cross-ticker track record shows 8 prior open-market buys with a 100% 90-day win rate and average 90-day return of +133.2%, though the same-ticker history at RZLT is more limited: 2 of 2 prior measurable buys were well-timed (March trades returning +59.6% and +22.5% at 30 days, and +205.0% and +190.1% at 90 days). The repeated accumulation within a compressed timeframe and strong prior outcomes at this ticker warrant attention, though the company remains unprofitable with a full-year net income of $-17.0M.